Alaunos Therapeutics | ZIOP - Sales Revenues


Alaunos Therapeutics reported $2K in Sales Revenues for its fiscal quarter ending in March of 2025.





Sales Change Date
Alaunos Therapeutics USD 2K 2K Mar/2025
Amgen USD 8.62B 1.28B Mar/2026
AstraZeneca USD 15.29B 213M Mar/2026
Baxter International USD 2.7B 270M Mar/2026
Biogen USD 2.25B 30M Mar/2026
Bioline Rx USD 427K 123K Sep/2025
Bristol-Myers Squibb USD 11.49B 1.01B Mar/2026
Celltrion KRW 1.15T 180B Mar/2026
Corcept Therapeutics USD 164.9M 37.22M Mar/2026
Cspc Pharmaceutical CNY 6.47B 355.1M Mar/2026
Curis USD 1.14M 1.41M Dec/2025
Deva Holding AS TRY 2.32B 418.58M Sep/2023
Dianthus Therapeutics USD 284K 112K Dec/2025
Divis Laboratories Ltd INR 28.31B 2.27B Mar/2026
Gilead Sciences USD 7B 930M Mar/2026
GlaxoSmithKline GBP 7.63B 991M Mar/2026
Incyte USD 1.27B 240M Mar/2026
Intrexon USD 717K 511K Jun/2024
Ionis Pharmaceuticals USD 246M 43M Mar/2026
J&J USD 24.1B 500M Mar/2026
Kangmei Pharma CNY 1.08B 288.27M Mar/2026
Karyopharm Therapeutics USD 34.08M 3.54M Dec/2025
Knight Therapeutics CAD 133.11M 11.56M Dec/2025
Laboratorios Farma EUR 448.66M 67.82M Dec/2023
Medical Developments International AUD 21.57M 12.04M Dec/2025
Merck USD 16.29B 110M Mar/2026
Neuren Pharmaceuticals AUD 42.24M 28.1M Dec/2025
Novartis USD 13.11B 226M Mar/2026
Organigram Holdings CAD 63.54M 16.52M Dec/2025
Pfizer USD 14.5B 3.08B Mar/2026
Pharma Mar EUR 42.9M 47.3M Mar/2026
PTC Therapeutics USD 273M 108.3M Mar/2026
Qiagen NV USD 419.22M 38.16M Mar/2026
Regeneron Pharmaceuticals USD 3.6B 280M Mar/2026
Roche Holding CHF 15.65B 274.5M Dec/2025
Sangamo BioSciences USD 356K 125K Jun/2024
Sartorius EUR 899.1M 28.5M Mar/2026
Sino Biopharmaceutical CNY 14.26B 3.31B Dec/2025
TG Therapeutics USD 194.8M 2.23M Mar/2026
Tilray USD 217.51M 74.75M Dec/2025
Verastem USD 17.54M 7.53M Dec/2025
Zealand Pharma A/S 68.91M 19.35M Dec/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 2.72B 837.63M Mar/2026